UCSF-Stanford CERSI/Gilead Postdoctoral Fellowship in Regulatory Science


In the past decade, a plethora of new healthcare products have been developed, including innovative drugs for rare diseases, genome and cell-based therapies, mobile health products and implantable devices. Corresponding to the surge in these innovative products, there has been a scarcity of well-trained individuals to expertly evaluate them for safe and effective use. In fact, regulatory agencies such as the FDA as well as medical product developers have a shortage of highly trained individuals with knowledge of a broad spectrum of regulatory sciences.

The educational mission of the UCSF-Stanford CERSI is to train a new generation of scientists by providing opportunities to broaden their knowledge about tools, methods, and standards to support regulatory science and medical product development.

The UCSF-Stanford CERSI/Gilead postdoctoral fellowship is an experiential program that will provide the most outstanding postdocs an opportunity to conduct research at UCSF/Stanford, FDA and Gilead in fields such as biomarkers, diagnostics, molecular epidemiology, clinical pharmacology and pharmacometrics, machine learning, and real-world evidence (RWE).

Training Components

Our objective is that the fellow should have a sufficient foundation and breadth in his/her training to engage in and serve as an ambassador for regulatory science research and education. The fellow will receive a monthly stipend commensurate with education level and experience. The fellow will spend the first year at UCSF or Stanford, and the second year at the FDA. At the end of two years, the fellow will complete an additional year (after completion of the academic and FDA rotations) at Gilead Sciences. Throughout the fellowship, the fellow will be paired with a Gilead scientist who will serve as a mentor. The anticipated start date of the first year fellowship in academia will be on or around July 1, 2024. The fellowship components are:

Research and Training at UCSF (1 year)

During the first year, the fellow is expected to spend at least 90% of his/her time on a scientific research project under the mentorship of a UCSF or Stanford faculty member. The research project will either extend an existing project or will be an entirely new one-year project. In addition to research, the fellow will enroll and successfully complete the UCSF-Stanford CERSI Immersion Course in Drug Discovery, Drug Development, and Regulation. The fellow is also expected to actively participate in all CERSI seminars, meetings and events.

Immersion Experience at FDA

The fellow will be assigned an FDA mentor and will work on a regulatory science research project under the mentorship of an FDA scientist. This project may be a continuation of the fellow’s academic research project, or a new FDA project. We will discuss research project interests with the fellow during his/her first year. The fellow will have an opportunity to attend seminars and workshops held by the FDA to augment the learning experience on different aspects of regulatory science. Furthermore, the fellow is required to attend the annual UCSF-Stanford CERSI Innovations in Regulatory Science Summit.

Immersion Experience in Industry (1 year)

The fellow will complete a year (after completion of the academic and FDA rotations) at Gilead Sciences, where they will work under the supervision of a Gilead scientist on a research project relating to biomarkers, diagnostics, molecular epidemiology, clinical pharmacology, pharmacometrics, machine learning, or real-world evidence (RWE). The fellow is required to attend the annual UCSF-Stanford CERSI Innovations in Regulatory Science Summit.

Statement of Completion and Employment

Fellows will receive a document certifying their participation in the regulatory science fellowship upon completion of all training components. Please note that the immersive experiences in academia, the FDA, and at Gilead do not guarantee job placements.

Eligibility Criteria

Applicants must hold a doctoral degree (PhD in pharmaceutical sciences, chemical and biomedical engineering, applied mathematics, or biomedical sciences or another related field, or hold a PharmD). The candidate must have an excellent record of academic achievement. As the Fellow will perform work at the FDA, all candidates must be a U.S. citizen or otherwise meet the ORISE Non-U.S. Citizen Requirements (see https://orise.orau.gov/fda/applicants/default.html#immigrant). Applicants may not be current FDA employees, contractors, or fellows.

2023-2024 Application Process


July 1, 2023 Application filing period opens
November 10, 2023 Application filing period closes
Nov-Dec 2023 Applications reviewed and interviews conducted
Jan-Feb 2023 Recipients notified
July 1, 2024 Fellowship start date

How to Apply

Interested applicants must complete the UCSF School of Pharmacy’s Centralized Fellowship Application Form, which will allow you to submit one application for multiple fellowship programs under the UCSF School of Pharmacy.

Apply Now

Please be prepared to:

  1. Enter your personal information.
  2. Enter your Statement of Interest (1,000 words max).
  3. Upload a PDF of your CV (5 pages max).
  4. Upload a single PDF of your professional/graduate school transcripts (unofficial ok).
  5. Confirm that you have requested Letters of Recommendation from two individuals who will submit by the application deadline.
  6. Provide the names and contact information for your three letter writers.

Selection Process

Applications will be reviewed by UCSF/Stanford faculty and Gilead scientists.

UCSF will be the home institution for all fellows.

Learn more

Attend one of our informational webinars to learn more about this program, other fellowships in the UCSF School of Pharmacy, and the application process. These webinars will not be recorded.

Date and Zoom link Pacific Time Meeting ID Password
Fri 7/14/23 9:15-10:00 am 979 3271 8414 654357
Tues 8/18/23 12:15-1:00 pm 952 5040 9149 245540
Thurs 9/14/23 10:15-11:00 am 928 4129 8102


The UCSF-Stanford CERSI/Gilead Postdoctoral Fellowship in Regulatory Science is supported by Gilead Sciences, Inc.